Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections
出版年份 2015 全文链接
标题
Diagnostic and prognostic role of procalcitonin (PCT) and MR-pro-Adrenomedullin (MR-proADM) in bacterial infections
作者
关键词
-
出版物
APMIS
Volume 123, Issue 9, Pages 740-748
出版商
Wiley
发表日期
2015-06-11
DOI
10.1111/apm.12406
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective
- (2015) Philipp Schuetz et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Prognostic value of pro-adrenomedullin, procalcitonin and C-reactive protein in predicting outcome of febrile urinary tract infection
- (2014) W.E. van derStarre et al. CLINICAL MICROBIOLOGY AND INFECTION
- The Utility of Proadrenomedullin and Procalcitonin in Comparison to C-Reactive Protein as Predictors of Sepsis and Bloodstream Infections in Critically Ill Patients With Cancer*
- (2014) Labib Debiane et al. CRITICAL CARE MEDICINE
- Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock
- (2013) Andreas Hohn et al. BMC INFECTIOUS DISEASES
- Pro-adrenomedullin as a Novel Biomarker for Predicting Infections and Response to Antimicrobials in Febrile Patients With Hematologic Malignancies
- (2013) Munirah Al Shuaibi et al. CLINICAL INFECTIOUS DISEASES
- Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis
- (2013) Philipp Schuetz et al. Current Opinion in Critical Care
- Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission
- (2013) B. Suberviola et al. INTENSIVE CARE MEDICINE
- Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
- (2013) R. P. Dellinger et al. INTENSIVE CARE MEDICINE
- Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis
- (2013) Christina Wacker et al. LANCET INFECTIOUS DISEASES
- Changes in Circulating Procalcitonin Versus C-Reactive Protein in Predicting Evolution of Infectious Disease in Febrile, Critically Ill Patients
- (2013) Sandra H. Hoeboer et al. PLoS One
- Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score
- (2012) Francesco Travaglino et al. BMC INFECTIOUS DISEASES
- Procalcitonin and mid-regional pro-adrenomedullin test combination in sepsis diagnosis
- (2012) Silvia Angeletti et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
- (2010) Lila Bouadma et al. LANCET
- Homogeneous time-resolved fluoroimmunoassay for the measurement of midregional proadrenomedullin in plasma on the fully automated system B.R.A.H.M.S KRYPTOR®
- (2009) Pascaline Caruhel et al. CLINICAL BIOCHEMISTRY
- Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract Infections
- (2009) Philipp Schuetz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Risk Prediction With Procalcitonin and Clinical Rules in Community-Acquired Pneumonia
- (2008) David T. Huang et al. ANNALS OF EMERGENCY MEDICINE
- Procalcitonin-Guided Antibiotic Use vs a Standard Approach for Acute Respiratory Tract Infections in Primary Care
- (2008) Matthias Briel et al. ARCHIVES OF INTERNAL MEDICINE
- Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes
- (2007) S. Kruger et al. EUROPEAN RESPIRATORY JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More